We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+1.87%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$7.28M
(-6.5%)
Cap. Flow
-$7.72M
Cap. Flow
% of AUM
-7.33%
Top 10 Holdings %
Top 10 Hldgs %
26.55%
Holding
118
New
2
Increased
12
Reduced
41
Closed
12
Avg Time Held
4.9
quarters
Top 10 Avg Time Held
2.4
quarters
Top 20 Avg Time Held
3.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS
ARP
|
+$939K |
| 2 |
LMRK
Landmark Infrastructure Partners LP Common Units
LMRK
|
+$519K |
| 3 |
AGN
Allergan plc
AGN
|
+$315K |
| 4 |
VivoSim Labs
VIVS
|
+$238K |
| 5 |
Navigator Holdings
NVGS
|
+$130K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harvard Bioscience
HBIO
|
+$1.62M |
| 2 |
CALL
magicJack VocalTec Ltd
CALL
|
+$938K |
| 3 |
VTSS
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
|
+$933K |
| 4 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$829K |
| 5 |
AFFX
Affymetrix Inc
AFFX
|
+$802K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.52% |
| 2 | Healthcare | 14.97% |
| 3 | Miscellaneous | 13.49% |
| 4 | Financials | 10.99% |
| 5 | Energy | 10.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Becton Dickinson
BDX
$50.1B
| $453K | 0.43% |
3,280
| – | – |
2013 Q4
6 quarters
|
|
|
SA
77
Seabridge Gold
SA
$3.03B
| $414K | 0.39% |
67,835
-20,680
| -23% | -$130K |
2013 Q4
6 quarters
|
|
78
John Wiley & Sons Class A
WLY
$2.52B
| $408K | 0.39% |
7,500
| – | – |
2013 Q4
6 quarters
|
|
|
RLOC
79
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
| $398K | 0.38% |
126,560
| – | – |
2014 Q2
4 quarters
|
|
80
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $395K | 0.38% |
43,000
| – | – |
2014 Q4
2 quarters
|
|
81
Apple
AAPL
$4.91T
| $389K | 0.37% |
12,420
-68
| -0.5% | -$2.17K |
2013 Q4
6 quarters
|
|
|
WMAR
82
DELISTED
West Marine Inc
WMAR
| $379K | 0.36% |
39,335
| – | – |
2014 Q2
4 quarters
|
|
|
EPIQ
83
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $359K | 0.34% |
21,265
-19,577
| -48% | -$339K |
2014 Q2
4 quarters
|
|
84
Gilead Sciences
GILD
$187B
| $351K | 0.33% |
3,000
-1,000
| -25% | -$109K |
2014 Q3
3 quarters
|
|
|
TECU
85
DELISTED
TECUMSEH PRODUCTS COMPANY COMMON STOCK
TECU
| $337K | 0.32% |
136,475
| – | – |
2014 Q2
4 quarters
|
|
86
ExxonMobil
XOM
$695B
| $302K | 0.29% |
3,635
-1,497
| -29% | -$129K |
2013 Q4
6 quarters
|
|
87
IBM
IBM
$214B
| $300K | 0.28% |
1,930
-853
| -31% | -$137K |
2013 Q4
6 quarters
|
|
|
CTRL
88
DELISTED
Control4 Corporation
CTRL
| $300K | 0.28% |
33,725
| – | – |
2014 Q4
2 quarters
|
|
|
NYV
89
DELISTED
Nuveen New York Municipal Value Fund 2
NYV
| $299K | 0.28% |
20,000
| – | – |
2013 Q4
6 quarters
|
|
90
AbbVie
ABBV
$489B
| $258K | 0.25% |
3,840
| – | – |
2014 Q2
4 quarters
|
|
91
PetMed Express
PETS
$27.7M
| $240K | 0.23% |
13,893
| – | – |
2013 Q4
6 quarters
|
|
92
Meta Platforms (Facebook)
META
$1.83T
| $223K | 0.21% |
2,600
| – | – |
2014 Q3
3 quarters
|
|
93
General Mills
GIS
$17.3B
| $214K | 0.2% |
3,840
| – | – |
2014 Q4
2 quarters
|
|
94
abrdn Asia-Pacific Income Fund
FAX
$531M
| $209K | 0.2% |
7,017
-1,933
| -22% | -$61.8K |
2013 Q4
6 quarters
|
|
|
BSTG
95
DELISTED
Biostage, Inc. Common Stock
BSTG
| $181K | 0.17% |
126,583
-10,411
| -8% | -$25.5K |
2013 Q4
6 quarters
|
|
96
Ford
F
$48.5B
| $176K | 0.17% |
11,700
-600
| -5% | -$9.3K |
2014 Q2
4 quarters
|
|
97
Lantronix
LTRX
$321M
| $154K | 0.15% |
93,339
| – | – |
2013 Q4
6 quarters
|
|
98
Invesco Municipal Trust
VKQ
$479M
| $120K | 0.11% |
10,000
| – | – |
2013 Q4
6 quarters
|
|
|
JPS
99
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
| $90K | 0.09% |
10,600
-6,819
| -39% | -$61K |
2015 Q1
1 quarter
|
|
|
CASM
100
DELISTED
CAS Medical Systems, Inc.
CASM
| $74K | 0.07% |
58,000
| – | – |
2013 Q4
6 quarters
|
|
Similar funds
AFW
QGA
AWA
BGAI
AIG
MFG
BCM
MCM
Penbrook Management's Q2 2015 Portfolio in Review
As of Q2 2015, Penbrook Management held 118 positions worth $105M, down 6.5% from $113M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Penbrook Management withdrew a net $7.72M in Q2 2015, closing 12 positions and reducing 41 holdings. Its most notable exit was magicJack VocalTec Ltd, an estimated $938K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Miscellaneous.
Against the trend, Penbrook Management opened a new position in Landmark Infrastructure Partners LP Common Units worth $491K.
- Penbrook Management's largest Q2 2015 buy was Landmark Infrastructure Partners LP Common Units: 30,400 shares worth $491K.
- Penbrook Management added most to ATLAS RESOURCE PARTNERS L P COM UIT REPSTG LTD PTNRS in Q2 2015, an estimated $939K increase.
- Penbrook Management's biggest Q2 2015 reduction was Harvard Bioscience, cutting an estimated $1.62M.
- Penbrook Management fully exited magicJack VocalTec Ltd in Q2 2015, selling an estimated $938K.
- Penbrook Management's ten largest holdings make up 27% of its $105M portfolio in Q2 2015.
- Penbrook Management opened 2 new positions and closed 12 in Q2 2015.
- Penbrook Management's portfolio value fell 6.5% quarter-over-quarter to $105M.
Based on Penbrook Management's 13F filing for Q2 2015, filed 4 Aug 2015.